Business
business

Peak big truck?

Sales of top full-sized pickups — the Ford F-150, Dodge Ram and Chevy Silverado — slumped, falling 10%, 15%, and 10% respectively — in the first quarter of 2024 compared to the last quarter of 2023. High prices and costly interest rates on auto loans appear to be taking a toll.

The decline prompts a question: Has the relentless American appetite for large trucks finally hit a wall? Bloomberg notes that smaller and mid-sized pickups appear to be taking market share.

More Business

See all Business
business

Monster surges on energy drink buzz, while Celsius sinks on distribution concerns

Shares of Monster Beverage climbed 5% after the bell on Thursday, and held most of those gains into early trading on Friday, following strong Q3 results.

The energy drink giant topped market expectations, with quarterly sales up 17% year over year to $2.2 billion and adjusted net profits growing 41% to $524.5 million — 11% ahead of Wall Street’s estimates. In the report, Monster highlighted its zero-sugar line and new product launches, with a stack of novel flavors already released this year, as bright spots.

During a call with analysts, Chief Executive Hilton Schlosberg said that the global energy drink category “remains healthy with robust growth,” The Wall Street Journal reported, adding that demand for more affordable caffeinated drinks is rising as coffee has become “really expensive.”

Meanwhile, rival beverage business Celsius saw shares fall as much as 23% on its Q3 results yesterday — despite beating expectations, with revenue jumping 173% — largely due to concerns about a change in the company’s distribution channel, as its newly acquired Alani Nu brand joins the PepsiCo distribution network.

President Trump Announces Negotiated Lower Prices For GLP-1 Weight Loss Drugs

White House unveils deal with Novo, Lilly on weight-loss drugs

The latest deal the administration has reached with Big Pharma is perhaps the one that would impact the highest number of Americans.

Mounjaro injections

Blockbuster drug sales power Big Pharma’s Q3 earnings as tariff fears fade

Meanwhile, Novo Nordisk and Pfizer are in an escalating bid-off for obesity biotech Metsera.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.